<DOC>
	<DOCNO>NCT02866838</DOCNO>
	<brief_summary>Novel , non-vitamin K antagonist oral anticoagulant ( NOAC ) target select player coagulation cascade direct thrombin inhibitor dabigatran factor Xa-inhibitors apixaban rivaroxaban . Intracerebral hemorrhage ( ICH ) fear complication NOAC treatment ( NOAC-ICH ) . Outcome NOAC-ICH devastating major cause death disability . There proven treatment NOAC-ICH . Hematoma expansion ( HE ) associate unfavorable outcome . Tranexamic acid ( TA ) anti-fibrinolytic drug use number bleed condition ICH .</brief_summary>
	<brief_title>Treatment Intracerebral Hemorrhage Patients Non-vitamin K Antagonist</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Acute intracerebral hemorrhage ( symptom onset &lt; 12h ) Prior treatment novel direct oral anticoagulant ( apixaban , dabigatran , edoxaban rivaroxaban ; last intake &lt; 48hours proven NOAC activity relevant coagulation assay ) Age &gt; 18 year , No upper age limit Informed consent receive accordance local ethic committee requirement Severe premorbid disability ( modify Rankin scale &gt; 4 ) Anticoagulation Vitamin K antagonist ( VKA ) ( recent intake ) Secondary intracerebral hemorrhage ( e.g . arteriovenous malformation ( AVM ) , tumor , trauma ) Note necessary investigator exclude underlying structural abnormality prior enrolment , underlie structural abnormality already know , patient recruit . Glasgow coma scale &lt; 5 pregnancy Planned neurosurgical hematoma evacuation within 24 hour ( followup imaging ) Pulmonary embolism/deep vein thrombosis within last 2 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Tranexamic acid</keyword>
	<keyword>NOAC</keyword>
	<keyword>Direct Oral Anticoagulant ( DOAC )</keyword>
	<keyword>Direct oral anticoagulant</keyword>
	<keyword>Non-Vitamin K antagonist oral anticoagulant</keyword>
</DOC>